These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 6207969)

  • 1. T-cell subsets regulating anti-acetylcholine-receptor-antibody formation in myasthenia gravis and characterization of suppressor T-cell factors involved.
    Shinomiya N; Yata J; Sasazuki T
    Clin Immunol Immunopathol; 1984 Nov; 33(2):182-90. PubMed ID: 6207969
    [TBL] [Abstract][Full Text] [Related]  

  • 2. B and T cell involvement in anti-acetylcholine receptor antibody formation in myasthenia gravis.
    Shinomiya N; Yata J
    Clin Exp Immunol; 1981 Nov; 46(2):277-85. PubMed ID: 6978218
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Anti-AChR antibodies, thymic histology, and T cell subsets in myasthenia gravis.
    Berrih S; Morel E; Gaud C; Raimond F; Le Brigand H; Bach JF
    Neurology; 1984 Jan; 34(1):66-71. PubMed ID: 6228745
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Production of anti-acetylcholine receptor-alpha antibody in vitro by peripheral blood lymphocytes of patients with myasthenia gravis: role of immunoregulatory T cells and monocytes.
    Ofosu-Appiah W; Mokhtarian F; Shirazian D; Grob D
    J Lab Clin Med; 1994 Aug; 124(2):231-41. PubMed ID: 8051487
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In vitro synthesis of antibodies to acetylcholine receptor by peripheral blood cells: role of suppressor T cells in normal subjects.
    Lisak RP; Laramore C; Levinson AI; Zweiman B; Moskovitz AR; Witte A
    Neurology; 1984 Jun; 34(6):802-5. PubMed ID: 6233499
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Induction of suppressor cells specific for AChR in experimental autoimmune myasthenia gravis.
    McIntosh KR; Drachman DB
    Science; 1986 Apr; 232(4748):401-3. PubMed ID: 2938256
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Genetic restriction of autoreactive acetylcholine receptor-specific T lymphocytes in myasthenia gravis.
    Hohlfeld R; Conti-Tronconi B; Kalies I; Bertrams J; Toyka KV
    J Immunol; 1985 Oct; 135(4):2393-9. PubMed ID: 2411794
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Suppression of experimental autoimmune myasthenia gravis by epitope-specific neonatal tolerance to synthetic region alpha 146-162 of acetylcholine receptor.
    Shenoy M; Oshima M; Atassi MZ; Christadoss P
    Clin Immunol Immunopathol; 1993 Mar; 66(3):230-8. PubMed ID: 7679342
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effects of T cell subpopulations and recombinant interleukin (IL)-2 on peripheral B cell function in patients with myasthenia gravis.
    Zhang J; Zhou WB; Wang HL; Guo SS
    Hum Antibodies; 1997; 8(2):90-4. PubMed ID: 9289393
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Myasthenia gravis: stimulation of antireceptor autoantibodies by autoreactive T cell lines.
    Hohlfeld R; Kalies I; Kohleisen B; Heininger K; Conti-Tronconi B; Toyka KV
    Neurology; 1986 May; 36(5):618-21. PubMed ID: 3486379
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Regulation of antibody production by helper T cell clones in experimental autoimmune myasthenia gravis is mediated by IL-4 and antigen-specific T cell factors.
    Asthana D; Fujii Y; Huston GE; Lindstrom J
    Clin Immunol Immunopathol; 1993 Jun; 67(3 Pt 1):240-8. PubMed ID: 7684661
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Specific immune complexes augment in vitro acetylcholine receptor-specific T-cell proliferation.
    Melms A; Weissert R; Klinkert WE; Schalke BC; Tzartos S; Wekerle H
    Neurology; 1993 Mar; 43(3 Pt 1):583-8. PubMed ID: 7680803
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Specific activation of lymphocytes against acetylcholine receptor in the thymus in myasthenia gravis.
    Fujii Y; Hashimoto J; Monden Y; Ito T; Nakahara K; Kawashima Y
    J Immunol; 1986 Feb; 136(3):887-91. PubMed ID: 2416838
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Phenotypic and functional characterization of T cells from patients with myasthenia gravis.
    Mokhtarian F; Pino M; Ofosu-Appiah W; Grob D
    J Clin Invest; 1990 Dec; 86(6):2099-108. PubMed ID: 1979338
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The T-cell repertoire in myasthenia gravis involves multiple cholinergic receptor epitopes.
    Link H; Xu ZY; Melms A; Kalbacher H; Sun JB; Wang ZY; Fredrikson S; Olsson T
    Scand J Immunol; 1992 Sep; 36(3):405-14. PubMed ID: 1381518
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Induction of acetylcholine receptor-specific suppression. An in vitro model of antigen-specific immunosuppression in myasthenia gravis.
    Bogen S; Mozes E; Fuchs S
    J Exp Med; 1984 Jan; 159(1):292-304. PubMed ID: 6198424
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Anti-acetylcholine receptor antibodies.
    Vincent A; Newsom Davis J
    J Neurol Neurosurg Psychiatry; 1980 Jul; 43(7):590-600. PubMed ID: 7400823
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Specific immunotherapeutic strategy for myasthenia gravis: targeted antigen-presenting cells.
    Reim J; McIntosh K; Martin S; Drachman DB
    J Neuroimmunol; 1992 Nov; 41(1):61-70. PubMed ID: 1460093
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Acetylcholine receptor antibody-producing cells in thymus and lymph nodes in myasthenia gravis.
    Fujii Y; Monden Y; Hashimoto J; Nakahara K; Kawashima Y
    Clin Immunol Immunopathol; 1985 Jan; 34(1):141-6. PubMed ID: 4038384
    [TBL] [Abstract][Full Text] [Related]  

  • 20. On the initial trigger of myasthenia gravis and suppression of the disease by antibodies against the MHC peptide region involved in the presentation of a pathogenic T-cell epitope.
    Atassi MZ; Oshima M; Deitiker P
    Crit Rev Immunol; 2001; 21(1-3):1-27. PubMed ID: 11642597
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.